Biphalin, an opioid peptide analog, decreases the proliferation of glioma cells [82], methionine-enkephalin promotes apoptosis in glioma cells [83], and the ligand of the NPY 1 receptor, [Asn6, Pro34] NPY, increases the survival rate [125]. This evidence concerns the gene NPY and central nervous system cancer.